Tech Company Financing Transactions

ProSomnus Sleep Technologies Funding Round

ProSomnus Sleep Technologies closed a $38 million funding round on 2/18/2026. Investors included Catalio Capital Management.

Transaction Overview

Announced On
2/18/2026
Transaction Type
Venture Equity
Amount
$38,000,000
Round
Undisclosed
Proceeds Purpose
The company plans to use the funds to accelerate the global expansion of its technology-enabled sleep health platform.

Company Information

Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
5675 Gibraltar Drive
Pleasanton, CA 94588
USA
Email Address
Overview
ProSomnus is the leading non-CPAP OSA therapy® for the treatment of Obstructive Sleep Apnea, a serious medical disease affecting over 1 billion people worldwide, that is associated with comorbidities including heart failure, stroke, hypertension, morbid obesity, and type 2 diabetes. ProSomnus intraoral medical devices are engineered to precisely track the treatment plan and anatomy for each patient. Non-invasive, patient preferred and easy to use, ProSomnus devices have demonstrated excellent efficacy, safety, adherence, and overall outcomes in a growing body of clinical investigations. ProSomnus precision intraoral devices are FDA-cleared, patented, and covered by commercial medical insurance, Medicare, TRICARE and many Government sponsored healthcare plans around the world, representing over 200 million covered lives.
Profile
ProSomnus Sleep Technologies LinkedIn Company Profile
Social Media
ProSomnus Sleep Technologies Company Twitter Account
Company News
ProSomnus Sleep Technologies News
Facebook
ProSomnus Sleep Technologies on Facebook
YouTube
ProSomnus Sleep Technologies on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Len Liptak
  Len Liptak LinkedIn Profile  Len Liptak Twitter Account  Len Liptak News  Len Liptak on Facebook
Chief Financial Officer
Jason Orchard
  Jason Orchard LinkedIn Profile  Jason Orchard Twitter Account  Jason Orchard News  Jason Orchard on Facebook
Chief Medical Officer
Edward Sall
  Edward Sall LinkedIn Profile  Edward Sall Twitter Account  Edward Sall News  Edward Sall on Facebook
Chief Scientific Officer
Erin Mosca
  Erin Mosca LinkedIn Profile  Erin Mosca Twitter Account  Erin Mosca News  Erin Mosca on Facebook
Chief Technical Officer
Sung Kim
  Sung Kim LinkedIn Profile  Sung Kim Twitter Account  Sung Kim News  Sung Kim on Facebook
VP - Bus. Development
Gregory Vogel
  Gregory Vogel LinkedIn Profile  Gregory Vogel Twitter Account  Gregory Vogel News  Gregory Vogel on Facebook
VP - Finance
Brock Beal
  Brock Beal LinkedIn Profile  Brock Beal Twitter Account  Brock Beal News  Brock Beal on Facebook
VP - Marketing
Heather Whalen
  Heather Whalen LinkedIn Profile  Heather Whalen Twitter Account  Heather Whalen News  Heather Whalen on Facebook
VP - Sales
Jerry Vogel
  Jerry Vogel LinkedIn Profile  Jerry Vogel Twitter Account  Jerry Vogel News  Jerry Vogel on Facebook


 

 

Browse more venture capital transactions:

Prev: 2/18/2026: Nihin Media venture capital transaction
Next: 2/18/2026: Efficient Computer venture capital transaction

 

Share this article

 


About Our Venture Capital Transactions Database

We do our best to record every notable VC transaction. All VC database entries reported here are sourced from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary